These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 34251799

  • 21. Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacology.
    Lepailleur A, Freret T, Lemaître S, Boulouard M, Dauphin F, Hinschberger A, Dulin F, Lesnard A, Bureau R, Rault S.
    J Chem Inf Model; 2014 Jun 23; 54(6):1773-84. PubMed ID: 24857631
    [Abstract] [Full Text] [Related]

  • 22. Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties.
    McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG.
    Bioorg Med Chem Lett; 2013 Jul 15; 23(14):4210-5. PubMed ID: 23756062
    [Abstract] [Full Text] [Related]

  • 23. Therapeutic modulators of the serotonin 5-HT4 receptor: a patent review (2014-present).
    Lanthier C, Dallemagne P, Lecoutey C, Claeysen S, Rochais C.
    Expert Opin Ther Pat; 2020 Jul 15; 30(7):495-508. PubMed ID: 32400221
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.
    Brudeli B, Andressen KW, Moltzau LR, Nilsen NO, Levy FO, Klaveness J.
    Bioorg Med Chem; 2013 Nov 15; 21(22):7134-45. PubMed ID: 24113240
    [Abstract] [Full Text] [Related]

  • 26. 5-HT4-mediated neuroprotection: a new therapeutic modality on the way?
    Gershon MD.
    Am J Physiol Gastrointest Liver Physiol; 2016 May 15; 310(10):G766-7. PubMed ID: 27012772
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The novel, potent and highly selective 5-HT4 receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility.
    Jeong EJ, Chung SY, Hong HN, Oh SW, Sim JY.
    Br J Pharmacol; 2018 Feb 15; 175(3):485-500. PubMed ID: 29139561
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Déjà-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task.
    de Cates AN, Wright LC, Martens MAG, Gibson D, Türkmen C, Filippini N, Cowen PJ, Harmer CJ, Murphy SE.
    Transl Psychiatry; 2021 Oct 04; 11(1):497. PubMed ID: 34602607
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease.
    Baranger K, Giannoni P, Girard SD, Girot S, Gaven F, Stephan D, Migliorati M, Khrestchatisky M, Bockaert J, Marchetti-Gauthier E, Rivera S, Claeysen S, Roman FS.
    Neuropharmacology; 2017 Nov 04; 126():128-141. PubMed ID: 28844596
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The in vitro pharmacology and non-clinical cardiovascular safety studies of a novel 5-HT4 receptor agonist, DSP-6952.
    Tsubouchi T, Kunimatsu T, Tsujimoto S, Kiyoshi A, Katsura Y, Oku S, Chihara K, Mine Y, Yamada T, Shimizu I, Bando K.
    Eur J Pharmacol; 2018 May 05; 826():96-105. PubMed ID: 29501863
    [Abstract] [Full Text] [Related]

  • 40. 5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.
    Cochet M, Donneger R, Cassier E, Gaven F, Lichtenthaler SF, Marin P, Bockaert J, Dumuis A, Claeysen S.
    ACS Chem Neurosci; 2013 Jan 16; 4(1):130-40. PubMed ID: 23336052
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.